XML 19 R10.htm IDEA: XBRL DOCUMENT v3.21.2
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT
6 Months Ended
Jun. 30, 2021
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT  
FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT

4.FINANCIAL INSTRUMENTS AND RISKS MANAGEMENT

4.1.Financial risks management

4.1.1.Overview

In the six-month period ended June 30, 2021, there were no significant changes in the financial risk management policies and procedures compared to those disclosed in Note 4 to the annual financial statements for the year ended December 31, 2020.

The Company maintained its conservative approach and strong cash and marketable securities position, as well as its hedge policy, during the crisis caused by the pandemic of COVID-19 and even though there were impacts on the fair value of its financial instruments due to the effects on all global economies, the impacts were as expected, according to sensitivity analyses disclosed in previous reports, and measures were taken in relation to the risks associated to the financial instruments, in particular to the risks of liquidity, credit and exchange rate variation, as set forth below.

4.1.2.Rating

All transactions with financial instruments are recognized for accounting purposes and classified in the following categories:

June 30,

December 31,

    

Note

    

2021

    

2020

Assets

Amortized cost

Cash and cash equivalents

5

8,585,570

6,835,057

Trade accounts receivable

7

3,979,086

2,915,206

Other assets (1)

780,449

974,265

13,345,105

10,724,528

Fair value through other comprehensive income

Other investments - Celluforce

14.1

26,121

26,338

26,121

26,338

Fair value through profit or loss

Derivative financial instruments

4.5.1

1,968,997

1,341,420

Marketable securities

6

2,685,612

2,396,857

4,654,609

3,738,277

18,025,835

14,489,143

Liabilities

Amortized cost

Trade accounts payable

17

2,575,168

2,361,098

Loans, financing and debentures

18.1

68,476,998

72,899,882

Lease liabilities

19.2

5,366,994

5,191,760

Liabilities for assets acquisitions and associates

23

509,369

502,228

Dividends payable

11,185

6,232

Other liabilities (1)

159,079

459,684

77,098,793

81,420,884

Fair value through profit or loss

Derivative financial instruments

4.5.1

6,071,817

8,117,400

6,071,817

8,117,400

83,170,610

89,538,284

65,144,775

75,049,141

1)Does not include items not classified as financial instruments.

4.1.3.Fair value of loans and financing

The estimated fair values of loans and financing are set forth below:

Yield used

June 30,

December 31,

    

to discount

    

2021

    

2020

Quoted in the secondary market

In foreign currency

Bonds

Secondary Market

41,994,147

43,703,482

Estimated to present value

In foreign currency

Export credits ("Prepayment")

LIBOR

19,097,350

20,546,778

In local currency

BNDES – TJLP

DI 1

384,510

1,399,177

BNDES - TLP

DI 1

564,989

647,235

BNDES – Fixed

DI 1

60,143

76,732

BNDES – Selic ("Special Settlement and Custody System")

DI 1

574,915

960,215

BNDES - Currency basket

DI 1

24,977

27,239

CRA ("Agribusiness Receivables Certificate")

DI 1/IPCA

3,284,039

3,286,792

Debentures

DI 1

5,570,538

5,498,793

NCE ("Export Credit Notes")

DI 1

1,330,402

1,322,813

NCR ("Rural Credit Notes")

DI 1

285,282

283,702

Export credits ("Prepayment")

DI 1

1,342,462

1,490,242

74,513,754

79,243,200

The Management considers that for its other financial liabilities measured at amortized cost, its book values approximate to their fair values and therefore the information on their fair values is not being presented.

4.2.      Liquidity risk management

As disclosed in note 4 to annual the financial statements as of December 31, 2020, the Company’s purpose is maintaining a strong cash and marketable securities position to meet its financial and operating obligations. The amount held as cash is used for payments expected in the normal course of its operations, while the cash surplus amount is invested in highly liquid financial investments according to Cash Management Policy.

The cash position is monitored by the Company's senior management, by means of management reports and participation in performance meetings with determined frequency. In the six-month period ended June 30, 2021, the impacts in cash and marketable securities were as expected and the cash generated in the operation was used for the most part to debt redemption, including in advance.

The remaining contractual maturities of financial liabilities are disclosed at the date of this financial information reporting date. The amounts as set forth below, consist in the undiscounted cash flows and include interest payments and exchange rate variation, and therefore may not be reconciled with the amounts disclosed in the balance sheet.

June 30,

2021

Book

Future

Up to 1

1 - 2

More than

    

value

    

value

    

year

    

years

    

2 - 5 years

    

5 years

Liabilities

Trade accounts payables

2,575,168

2,575,168

2,575,168

Loans, financing and debentures

68,476,998

96,031,944

4,067,403

6,297,088

35,015,873

50,651,580

Lease liabilities

5,366,994

9,826,733

875,227

818,769

1,534,836

6,597,901

Liabilities for asset acquisitions and associates

509,369

569,469

115,495

134,525

228,985

90,464

Derivative financial instruments

6,071,817

8,643,168

1,052,089

933,750

5,706,969

950,360

Dividends payable

11,185

11,185

11,185

Other liabilities

473,085

473,085

361,197

111,888

83,484,616

118,130,752

9,057,764

8,296,020

42,486,663

58,290,305

December 31,

2020

Book

Future

Up to 1

1 - 2

More than

    

value

    

value

    

year

    

years

    

2 - 5 years

    

5 years

Liabilities

Trade accounts payables

2,361,098

2,361,098

2,361,098

Loans, financing and debentures

72,899,882

101,540,320

4,034,595

6,619,518

36,751,023

54,135,184

Lease liabilities

5,191,760

9,552,075

620,177

806,560

2,198,419

5,926,919

Liabilities for asset acquisitions and associates

502,228

573,920

116,376

112,155

253,419

91,970

Derivative financial instruments

8,117,400

10,868,858

1,999,811

1,296,199

4,133,320

3,439,528

Dividends payable

6,232

6,232

6,232

Other liabilities

459,684

459,684

360,916

98,768

89,538,284

125,362,187

9,499,205

8,933,200

43,336,181

63,593,601

4.3. Credit risk management

In the six-month period ended June 30, 2021, there were no significant changes in the credit risk management policies compared to those disclosed in Note 4 to the annual financial statements for the year ended of December 31, 2020, except for set forth below.

4.3.1.Trade accounts receivable  and advances to supplier

The Company has commercial and credit policies aimed at mitigating any risks arising from its customers' default, mainly through hiring of credit insurance policies, bank guarantees provided by first-tier banks and collaterals according to liquidity. Moreover, portfolio customers are subject to internal credit analysis aimed at assessing the risk regarding payment performance, both for exports and for domestic sales.

For customer credit assessment, the Company applies a matrix based on the analysis of qualitative and quantitative aspects to determine individual credit limits to each customer according to the identified risk. Each analyze is submitted for approval according to established hierarchy and, if applicable, to approval from the Management’s meeting and the Credit Committee.

4.3.2.Banks and financial institutions

In the six-month period ended June 30, 2021, there were no significant changes in the credit risk management policies and procedures related to bank and financial institutions compared to those disclosed in note 4 to the annual financial statements for the year ended December 31, 2020.

4.4.  Market risk management

In the six-month period ended June 30, 2021, there were no significant changes in the market risk management policies and procedures compared to those disclosed in note 4 to the annual financial statements for the year ended December 31, 2020.

4.4.1.Exchange rate risk management

As disclosed in note 4 of the annual financial statements for the year ended December 31, 2020, the Company hires U.S. Dollar selling transactions in the futures markets, including strategies involving options, to ensure attractive levels of operating margins for a portion of revenue. Such transactions are limited to a percentage of the net surplus foreign currency over an 18-months’ time horizon and therefore, are matched to the availability of currency for sale in the short term.

The net exposure of assets and liabilities in foreign currency which is substantially in U.S. Dollars, is set forth below:

June 30,

December 31,

    

2021

    

2020

Assets

Cash and cash equivalents

8,412,710

6,370,201

Trade accounts receivables

2,883,330

1,938,614

Derivative financial instruments

1,360,976

621,385

12,657,016

8,930,200

Liabilities

Trade accounts payables

(516,152)

(492,617)

Loans and financing

(55,187,953)

(58,145,087)

Liabilities for asset acquisitions and associates

(308,766)

(313,022)

Derivative financial instruments

(5,282,153)

(6,994,363)

(61,295,024)

(65,945,089)

Net liability exposure

(48,638,008)

(57,014,889)

4.4.1.1.Sensitivity analysis – foreign exchange rate exposure – except financial instruments derivatives

For market risk analysis, the Company uses scenarios to jointly evaluate assets and liabilities positions in foreign currency, and the possible effects on its results. The probable scenario represents the amounts recognized, as they reflect the translation into Brazilian Reais on the base date of the balance sheet (R$ to U.S.$ = R$5.0022).

This analysis assumes that all other variables, particularly, the interest rates, remains constant. The other scenarios considered the appreciation/depreciation of the Brazilian Real against the U.S. Dollar at the rates of 25% and 50%, before taxes.

The following table set forth the potential impacts in absolute amounts:

June 30,

2021

Effect on profit or loss and equity

Probable

Possible

Remote

    

(base value)

    

(25%)

    

(50%)

Cash and cash equivalents

8,412,710

2,103,178

4,206,355

Trade accounts receivable

2,883,330

720,833

1,441,665

Trade accounts payable

(516,152)

129,038

258,076

Loans and financing

(55,187,953)

13,796,988

27,593,977

Liabilities for asset acquisitions and associates

(308,766)

77,192

154,383

4.4.1.2.Sensitivity analysis – foreign exchange rate exposure – financial instruments derivatives

The Company hires sales operations of U.S. Dollar in the futures markets, including strategies with options, in order to ensure attractive levels of operating margins for a portion of revenue. These operations are limited to a percentage of the net foreign exchange surplus over the 18-month horizon and, therefore, are attached to the availability of ready-to-sell foreign exchange in the short term.

Due to pandemic of COVID-19 and the effects on all global economies over the past few quarters, financial markets have experienced volatility throughout the period with a strong sense of aversion to risk, with a consequent substantial devaluation of the Real against the U.S. Dollars.

For the calculation of mark-to-market (“MtM”), the PTAX of the penultimate business day of the quarter was used, in December 2020 it was R$5.1967 and in June 2021 it was R$5.0022, with an decrease of 3.74%. These market movements caused a positive impact on the mark-to-market hedge position entered by the Company.

This analysis assumes that all other variables, particularly, the interest rates, remains constant. The other scenarios considered the appreciation/depreciation of the Brazilian Real against the U.S. Dollar at the rates of 25% and 50%, before taxes, from the base scenario of June 30, 2021.

It is important to mention that the impact caused by fluctuations in the exchange rate, whether positive or negative, will also affect the hedged asset. Therefore, even though there was a negative impact on the fair value of derivative transactions in the period, this impact was partially offset by the positive effect on the Company’s cash flow and, if the exchange rate remains stable, it will be offset by the appreciation of the hedge object in the coming periods. In addition, considering that hedge contracts are limited by the policy in a maximum of 75% of the total exposure in U.S. Dollars, the exchange rate devaluation will always benefit, in a net way, the Company’s cash generation in the long run.

The following table set forth the potential impacts assuming these scenarios:

June 30,

2021

Effect on profit or loss and equity

Probable

Possible

Remote

Possible

Remote

    

(base value)

    

(+25%)

    

(+50%)

    

(-25%)

    

(-50%)

4.9450

6.1813

7.4175

3.7088

2.4725

Financial instruments derivatives

Derivative Non-Deliverable Forward (‘NDF’)

22,519

(99,451)

(198,903)

99,451

198,903

Derivative options

837,444

(2,825,652)

(7,098,368)

4,150,388

8,806,643

Derivative swaps

(5,305,415)

(4,101,386)

(8,202,776)

4,101,394

8,202,784

4.4.2.Interest rate risk management

Fluctuations in interest rates may imply effects of increased or reduced costs on new loans and operations already contracted.

The Company is constantly looking for alternatives for the use of financial instruments in order to avoid negative impacts on its cash flow.

Considering the extinction of LIBOR over the next few years, the Company is evaluating its contracts with clauses that envisage the discontinuation of the interest rate. Most debt contracts linked to LIBOR have some clause to replace this rate with a reference index or equivalent interest rate and, for contracts that do not have a specific clause, a renegotiation will be carried out between the parties. Derivative contracts linked to LIBOR provide for a negotiation between the parties for the definition of a new rate or an equivalent rate will be provided by the calculation agent.

It is worth mentioning that the clauses related to replacement of the indexes in the Company's debt contracts indexed to LIBOR, establish that any replacement of the indexation rate in the contracts can only be evaluated in two circumstances (i) after the communication from an official government entity with formalization of the replacement/extinguishment of the effective rate of the contract, and this communication must define the exact date on which LIBOR will be extinguished and / or (ii) syndicated operations begin to be executed at a rate indexed to the Secured Overnight Financing Rate (“SOFR”). Considering that on March 5, 2021, the Financial Conduct Authority (“FCA”) announced the date of extinction of LIBOR 3M for June 30, 2023, the Company can, from this announcement, start negotiations terms of exchange of indexes for its debt contracts and related derivatives.

The Company mapped all contracts subject to IBOR reform that have yet to transition to an alternative benchmark rate and for the six-month period ended June 30, 2021 the Company has R$18,542,667 related to loan and financing contracts and R$1,235,268 related to derivative contracts and, initiated contact with the respective counterparties of each contract, to ensure that the terms and good market practices are adopted at the time of the transition of the index until June 2023, and these terms are still under negotiation between the parties.

The Company understands that it will not be necessary to change the risk management strategy due to the change in the indexes of the financial contracts linked to LIBOR.

The Company believes it is reasonable to assume that the negotiation of the indexes in its contracts, will move towards to the replacement of LIBOR by SOFR, because the available information, so far, indicates that SOFR will be the new interest rate adopted by the capital market. Based on the information available, the Company does not expect to have significant impact on its debts and derivatives linked to LIBOR.

4.4.2.1.Sensitivity analysis – exposure to interest rates – except financial instruments derivatives

For market risk analysis, the Company uses scenarios to evaluate the sensitivity that variations in operations impacted by the rates: Interbank Deposit Rate (“CDI”), Long Term Interest Rate (“TJLP”), Special System for Settlement and Custody ("SELIC") and the London Interbank Offered Rate (“LIBOR”) which may impact the results. The probable scenario represents the amounts already booked, as they reflect the best estimate of the Management.

This analysis assumes that all other variables, particularly exchange rates, remain constant. The other scenarios considered appreciation/depreciation of 25% and 50% in the market interest rates.

The following table set forth the potential impacts in absolute amounts:

June 30,

2021

Effect on profit or loss and equity

Possible

Remote

    

Probable

    

(25%)

    

(50%)

CDI/SELIC

Cash and cash equivalents

17,302

180

359

Marketable securities

2,681,431

27,820

55,640

Loans and financing

(9,363,931)

97,151

194,302

TJLP

Loans and financing

(397,245)

4,578

9,156

LIBOR

Loans and financing

(17,943,585)

6,538

13,076

4.4.2.2.Sensitivity analysis – exposure to interest rates – financial instruments derivatives

This analysis assumes that all other variables remain constant. The other scenarios considered appreciation/depreciation of 25% and 50% in the market interest rates.

The following table set forth the potential impacts assuming these scenarios:

June 30,

2021

Effect on profit or loss and equity

Probable

Remote

Probable

Remote

    

Probable

    

(+25%)

    

(+50%)

    

(-25%)

    

(-50%)

CDI

Financial instruments derivatives

Liabilities

Derivative Non-Deliverable Forward (‘NDF’)

22,519

(2,045)

(4,050)

2,087

4,218

Derivative options

837,444

(117,913)

(230,101)

123,873

253,831

Derivative swaps

(5,305,415)

(27,707)

(54,491)

28,618

58,092

LIBOR

Financial instruments derivatives

Liabilities

Derivative swaps

(5,305,415)

72,227

144,448

(72,221)

(144,448)

4.4.2.3.Sensitivity analysis for changes in the consumer price index of the US economy

For the measurement of the probable scenario, the United States Consumer Price Index (US-CPI) was considered on December 31, 2020. The probable scenario was extrapolated considering an appreciation/depreciation of 25% and 50% in the US-CPI to define the possible and remote scenarios, respectively, in absolute amounts.

The following table set forth the potential impacts in absolute amounts:

June 30,

 

2021

 

Effect on profit or loss and equity

 

Probable

Possible

Remote

    

(base value)

    

(25%)

    

(50%)

2.5282%

3.1603%

3.7923%

Embedded derivative in forestry partnership and standing wood supply agreements

254,848

165,629

340,080

4.4.3.Commodity price risk management

The Company is exposed to commodity prices that reflect mainly on the pulp sale price in the foreign market. The dynamics of opening and closing production capacities in the global market and the macroeconomic conditions may have an impact on the Company´s operating results.

Through a specialized team, the Company monitors the hardwood pulp price and analyses future trends, adjusting the forecast that aims to assisting preventive measures to properly conduct the different scenarios. There is no liquid financial market to sufficiently mitigate the risk of a material portion of the Company's operations. Hardwood pulp price protection operations available on the market have low liquidity and low volume and large distortion in price formation. No relevant changes were observed in relation to pulp prices and future markets related to this index due to the crisis caused by the pandemic of COVID-19.

The Company is also exposed to international oil prices, which is reflected on logistical costs for selling to the export market and indirectly in the costs of other supplies. In this case, the Company evaluates the contracting of derivative financial instruments to mitigate the risk of price variation in its result.

On June 30, 2021, the Company did not a hire position to hedge its logistics costs (US$37,757 as of December 31, 2020).

4.5.       Derivative financial instruments

The Company determines the fair value of derivative contracts, which differ from the amounts realized in the event of early settlement due to bank spreads and market factors at the time of quotation. The amounts presented by the Company are based on an estimate using market factors and use data provided by third parties, measured internally and compared to calculations performed by external consultants and by counterparties.

Details of derivative financial instruments and their respective calculation methodologies are disclosed in note 4 to the annual financial statements for the year ended December 31, 2020.

4.5.1.Outstanding derivatives by type of contract, including embedded derivatives

The positions of outstanding derivatives are set forth below:

Notional value in U.S.$

Fair value

June 30,

December 31,

June 30,

December 31,

    

2021

    

2020

    

2021

    

2020

Instruments hired with protection strategy

Operational Hedge

ZCC

3,777,250

3,212,250

837,500

(780,457)

NDF (R$ x US$)

80,000

80,000

22,519

7,948

Debt hedge

Interest rate hedge

Swap LIBOR to Fixed (U.S.$)

3,600,000

3,683,333

(706,256)

(1,059,192)

Swap IPCA to CDI (notional in Brazilian Reais)

843,845

843,845

269,764

285,533

Swap IPCA to Fixed (U.S.$)

121,003

121,003

(85,924)

(114,834)

Swap CDI x Fixed (U.S.$)

2,267,057

2,267,057

(4,166,257)

(4,977,309)

Pre-fixed Swap to U.S.$ (U.S.$)

350,000

350,000

(529,014)

(508,328)

Commodity Hedge

Swap US-CPI (U.S.$) (1)

612,650

646,068

254,848

354,900

Swap VLSFO (2)

37,757

15,759

(4,102,820)

(6,775,980)

Current assets

1,204,841

484,043

Non-current assets

764,156

857,377

Current liabilities

(1,010,897)

(1,991,118)

Non-current liabilities

(5,060,920)

(6,126,282)

(4,102,820)

(6,775,980)

1)

The embedded derivative refers to swap contracts for the sale of US-CPI variations within the term of the forest partnership and standing wood supply contracts.

2)

As of December 31, 2020, includes Swap Brent, whose contracts were fully settled in the subsequent period.

The current contracts and the respective protected risks are set forth below:

(i)Swap CDI x Fixed US$: positions in conventional swaps exchanging the variation in the Interbank Deposit rate (“DI”) for a fixed rate in United States Dollars (“US$”). The objective is to change the debt index in Brazilian Reais to US$, in compliance with the Company's natural exposure of receivables in US$.
(ii)Swap IPCA x CDI: positions in conventional swaps exchanging variation of the Amplified Consumer Price Index (“IPCA”) for DI rate. The objective is to change the debt index in Reais, in compliance with the Company's cash position in Brazilian Reais, which is also indexed to DI.
(iii)IPCA swap x Fixed US$: positions in conventional swaps exchanging variation of the IPCA for a fixed rate in US$. The objective is to change the debt index in Brazilian Reais to US$, in compliance with the Company's natural exposure of receivables in US$.
(iv)Swap LIBOR x Fixed US$: positions in conventional swaps exchanging post-fixed rate (LIBOR) for a fixed rate in US$. The objective is to protect the cash flow from changes in the US interest rate.
(v)Pre Fixed Swap R$ x Fixed US$: positions in conventional swaps a fixed rate in Reais for a fixed rate in US$. The objective is to change the exposure of debts in Brazilian Reais to US$, in compliance with the Company's natural exposure of receivables in US$.
(vi)Zero-Cost Collar (“ZCC”): positions in an instrument that consists of the simultaneous combination of purchase of put options and sale of call options of US$, with the same principal and maturity value, with the objective of protecting the cash flow of exports. In this strategy, an interval is established where there is no deposit or receipt of financial margin upon expiration of options. The objective is to protect the cash flow of exports against decrease Real.
(vii) Non Deliverable Forward (“NDF”): positions sold in futures contracts of US$ with the objective of protecting the cash flow of exports against the decrease in the Brazilian Real.
(viii) Swap Very Low Sulphur Fuel Oil (“VLSFO”) (oil): oil purchase positions, with the objective of protecting logistical costs related to ocean freight contracts, against the increase in oil prices.
(ix)Swap US-CPI: The embedded derivative refers to sale swap contracts of variations of US-CPI within the terms of the forest partnership and standing wood supply contracts.

The variation in the fair value of derivatives for the six-month period ended June 30, 2021 compared to the fair value measured on December 31, 2020 is explained substantially by appreciation of the Brazilian Real against the U.S. Dollar. There were also less significant impacts caused by the variation in the Pre, Foreign Exchange Coupon and LIBOR curves in transactions.

It is important to highlight that, the outstanding agreements for the six-month period ended June 30, 2021, are over-the-counter market, without any kind of guaranteed margin or early settlement clause forced by changes from mark to market, including possible variations caused by the pandemic of COVID-19.

4.5.2.Fair value by maturity schedule

June 30,

December 31,

    

2021

    

2020

2021

74,613

(1,507,075)

2022

(258,065)

(918,030)

2023

(225,705)

(433,195)

2024

(578,197)

(705,859)

2025

(1,574,105)

(1,684,124)

2026 onwards

(1,541,361)

(1,527,697)

(4,102,820)

(6,775,980)

4.5.3.Outstanding of assets and liabilities derivatives positions

The outstanding derivatives positions are set forth below:

Notional value

Fair value

June 30,

December 31,

June 30,

December 31,

    

Currency

    

2021

    

2020

    

2021

    

2020

Debt hedge

Assets

Swap CDI to Fixed (U.S.$)

R$

8,594,225

8,594,225

102,173

719

Swap Pre-Fixed to U.S.$

R$

1,317,226

1,317,226

88,105

136,192

Swap LIBOR to Fixed (U.S.$)

US$

3,600,000

3,683,333

83,408

61,120

Swap IPCA to CDI

IPCA

1,019,028

974,102

269,764

285,533

Swap IPCA to U.S.$

IPCA

545,000

520,973

543,450

483,564

Liabilities

Swap CDI to Fixed (U.S.$)

US$

2,267,057

2,267,057

(4,268,430)

(4,978,028)

Swap Pre-Fixed to U.S.$

US$

350,000

350,000

(617,119)

(644,520)

Swap LIBOR to Fixed (U.S.$)

US$

3,600,000

3,683,333

(789,664)

(1,120,312)

Swap IPCA to CDI

R$

843,845

843,845

Swap IPCA to U.S.$

US$

121,003

121,003

(85,924)

(114,834)

(5,761,137)

(6,857,694)

(5,217,687)

(6,374,130)

Operational hedge

Zero cost collar (U.S.$ x R$)

US$

3,777,250

3,212,250

837,500

(780,457)

NDF (R$ x U.S.$)

US$

80,000

80,000

22,519

7,948

860,019

(772,509)

Commodity hedge

Swap US-CPI (standing wood)

US$

612,650

646,068

254,848

354,900

Swap VLSFO

US$

37,757

15,759

254,848

370,659

(4,102,820)

(6,775,980)

4.5.4.Fair value settled amounts

The settled derivatives positions are set forth below:

June 30,

December 31,

    

2021

    

2020

Operational hedge

Zero cost collar (R$ x U.S.$)

(1,161,276)

(2,268,158)

NDF (R$ x U.S.$)

(37)

(60,815)

(1,161,313)

(2,328,973)

Commodity hedge

Swap Bunker (oil)

53,840

(85,468)

53,840

(85,468)

Debt hedge

Swap CDI to Fixed (U.S.$)

(184,748)

(1,888,906)

Swap IPCA to CDI (notional in Brazilian Reais)

20,148

10,601

Swap IPCA to Fixed (U.S.$)

10,054

Swap Pre-Fixed to U.S.$

49,562

59,351

Swap LIBOR to Fixed (U.S.$)

(211,777)

(242,299)

(326,815)

(2,051,199)

(1,434,288)

(4,465,640)

4.6.    Fair value hierarchy

For the six-month period ended June 30, 2021, there were no changes between the 3 (three) levels of hierarchy and no transfers between levels 1, 2 and 3 during the periods disclosed.

June 30,

2021

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets

Fair value through profit or loss

Derivative financial instruments

1,968,997

1,968,997

Marketable securities

539,382

2,146,230

2,685,612

539,382

4,115,227

4,654,609

Fair value through other comprehensive income

Other investments - CelluForce

26,121

26,121

26,121

26,121

Biological assets

11,720,857

11,720,857

11,720,857

11,720,857

539,382

4,115,227

11,746,978

16,401,587

Liabilities

Fair value through profit or loss

Derivative financial instruments

6,071,817

6,071,817

6,071,817

6,071,817

6,071,817

6,071,817

December 31,

2020

Level 1

Level 2

Level 3

Total

Assets

Fair value through profit or loss

Derivative financial instruments

1,341,420

1,341,420

Marketable securities

444,712

1,952,145

2,396,857

444,712

3,293,565

3,738,277

Fair value through other comprehensive income

Other investments - CelluForce

26,338

26,338

26,338

26,338

Biological assets

11,161,210

11,161,210

11,161,210

11,161,210

444,712

3,293,565

11,187,548

14,925,825

Liabilities

Fair value through profit or loss

Derivative financial instruments

8,117,400

8,117,400

8,117,400

8,117,400

8,117,400

8,117,400

4.7.    Capital management

The main objective is to strengthen the Company’s capital structure, aiming to maintain an adequate financial leverage, and to mitigate risks that may affect the availability of capital in business development.

The Company monitors constantly significant indicators, such as, consolidated financial leverage, which is the ratio of total net debt to its adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (“Adjusted EBITDA”).